Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD's The Liver Meeting Digital Experience 2020

Media coverage

• Title	Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD's The Liver Meeting Digital Experience 2020
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	16/11/20
  Persons	John M Young